$Erratum to: Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer$

Erratum to: Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer

Bibliographic Details
Main Authors:	Jiménez-Fonseca, P., Solis, M. P., Garrido, M., Faez, L., Rodriguez, D., Ruiz, A. L., Sanchez Lorenzo, M. L., Uriol, E., Menendez, M. D., Viéitez, J. M.
Format:	Online
Language:	English
Published:	Springer Milan 2014
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4643580/

Similar Items

Gemcitabine plus capecitabine (Gem–Cape) biweekly in chemorefractory metastatic colorectal cancer
by: Jiménez-Fonseca, P., et al.
Published: (2014)

Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer
by: Stemmler, H J, et al.
Published: (2011)

Salvage chemotherapy of biweekly irinotecan plus S-1 (biweekly IRIS) in previously treated patients with advanced gastric cancer
by: Chon, Hong Jae, et al.
Published: (2011)

Bevacizumab plus chemotherapy as salvage treatment in chemorefractory patients with metastatic colorectal cancer
by: Geva, Ravit, et al.
Published: (2013)

A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer
by: Suenaga, Mitsukuni, et al.
Published: (2015)

Prospective phase II trial of pazopanib plus CapeOX (capecitabine and oxaliplatin) in previously untreated patients with advanced gastric cancer
by: Kim, Seung Tae, et al.
Published: (2016)

A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer
by: Choi, Jong Gwon, et al.
Published: (2012)

A phase II trial of a biweekly combination of paclitaxel and gemcitabine in metastatic breast cancer
by: Tomao, Silverio, et al.
Published: (2006)

Biweekly gemcitabine and paclitaxel in patients with relapsed or metastatic squamous cell carcinoma of the head and neck
by: Sukari, Ammar, et al.
Published: (2015)

Immunobiological effects of gemcitabine and capecitabine combination chemotherapy in advanced pancreatic ductal adenocarcinoma
by: Middleton, Gary, et al.
Published: (2016)

Weekly Paclitaxel plus Capecitabine versus Docetaxel Every 3 Weeks plus Capecitabine in Metastatic Breast Cancer
by: Wist, E. A., et al.
Published: (2012)

Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer
by: Lim, Jae Yun, et al.
Published: (2015)

A multicenter phase II study of biweekly capecitabine in combination with oxaliplatin as first-line chemotherapy in patients with locally advanced or metastatic gastric cancer
by: Chao, Yee, et al.
Published: (2014)

Outcomes of esophagectomy after chemotherapy with biweekly docetaxel plus cisplatin and fluorouracil for advanced esophageal cancer: a retrospective cohort analysis
by: Yuji Akiyama, et al.
Published: (2018-07-01)

Docetaxel plus cetuximab biweekly is an active regimen for the first-line treatment of patients with recurrent/metastatic head and neck cancer
by: Posch, Doris, et al.
Published: (2016)

Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma
by: Reni, Michele, et al.
Published: (2016)

A randomized, phase III trial of capecitabine plus bevacizumab (Cape-Bev) versus capecitabine plus irinotecan plus bevacizumab (CAPIRI-Bev) in first-line treatment of metastatic colorectal cancer: The AIO KRK 0110 Trial/ML22011 Trial
by: Giessen, Clemens, et al.
Published: (2011)

A Phase II Study of Sequential Capecitabine Plus Oxaliplatin Followed by Docetaxel Plus Capecitabine in Patients With Unresectable Gastric Adenocarcinoma: The TCOG 3211 Clinical Trial
by: Chen, Ming-Huang, et al.
Published: (2016)

Efficacy and safety of the third-generation chloroethylnitrosourea fotemustine for the treatment of chemorefractory T-cell lymphomas
by: Corazzelli, Gaetano, et al.
Published: (2011)

Anakoinosis: Communicative Reprogramming of Tumor Systems - for Rescuing from Chemorefractory Neoplasia
by: Hart, Christina, et al.
Published: (2015)

Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
by: Lee, Sung Uk, et al.
Published: (2013)

First-line chemotherapy with docetaxel plus capecitabine followed by capecitabine or hormone maintenance therapy for the treatment of metastatic breast cancer patients
by: LIANG, XU, et al.
Published: (2015)

Protocol of a randomised phase III clinical trial of sequential capecitabine or 5-fluorouracil plus bevacizumab (Cape/5-FU-Bmab) to capecitabine or 5-fluorouracil plus oxaliplatin plus bevacizumab (CapeOX/mFOLFOX6-Bmab) versus combination CapeOX/mFOLFOX6-Bmab in advanced colorectal cancer: the C-cubed (C3) study
by: Nagasaka, Takeshi, et al.
Published: (2016)

The efficacy and safety of CapeOX plus bevacizumab therapy followed by capecitabine plus bevacizumab maintenance therapy in patients with metastatic colorectal cancer: a multi-center, single-arm, phase II study (CCOG-0902)
by: Goro Nakayama, et al.
Published: (2017-04-01)

Bosutinib plus capecitabine for selected advanced solid tumours: results of a phase 1 dose-escalation study
by: Isakoff, S J, et al.
Published: (2014)

Finding the functional gems in plant genomes
by: Jones, Alexandra M, et al.
Published: (2003)

Phase I/II trial of a biweekly combination of S-1 plus docetaxel in patients with previously treated non-small cell lung cancer (KRSG-0601)
by: Komiyama, K, et al.
Published: (2012)

Gemcitabine-loaded albumin nanospheres (GEM-ANPs) inhibit PANC-1 cells in vitro and in vivo
by: Li, Ji, et al.
Published: (2013)

A randomized, placebo-controlled phase III trial of masitinib plus gemcitabine in the treatment of advanced pancreatic cancer
by: Deplanque, G., et al.
Published: (2015)

Severe hypertriglyceridaemia during treatment with capecitabine
by: Javot, L, et al.
Published: (2011)

Diamond detail and gem fraud status
by: J.D., Boles
Published: (2008)

Irradiation of Donor Mononuclear Cells for Treatment of Chemorefractory Metastatic Solid Cancers: A Community-Based Immune Transplant Pilot Study
by: Reynolds, John T., et al.
Published: (2012)

Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
by: Chiorean, E Gabriela, et al.
Published: (2016)

Second-line therapy after nab-paclitaxel plus gemcitabine or after gemcitabine for patients with metastatic pancreatic cancer
by: Chiorean, E Gabriela, et al.
Published: (2016)

Phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis: -KOGC04-
by: Matsuda, Satoru, et al.
Published: (2014)

Correction: phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis -KOGC04-
by: Matsuda, Satoru, et al.
Published: (2014)

The rare gem that is Armstrong
by: Abd Razak, Dzulkifli
Published: (2009)

GEM THERAPY AND EPILEPSY
by: Murthy, S.R.N., et al.
Published: (1990)

ROLE OF GEMS IN INDIAN MEDICINE
by: Murthy, S.R.N.
Published: (1991)

GEMS AND THEIR MEDICINAL VALUES
by: Sharma, A.V.
Published: (1989)